Results 31 to 40 of about 910,855 (274)

Deferasirox, an oral chelator in the treatment of iron overload

open access: yesItalian Journal of Medicine, 2013
BACKGROUND Deferasirox is a once-daily oral iron chelator developed for treating iron overload complicating long-term transfusion therapy in patients with diseases such as beta-thalassemia and myelodysplastic syndromes. Iron overload can damage the liver,
I. Portioli
doaj   +1 more source

Ocular Toxicity of Iron Chelator Drugs among Thalassemia Patients; a Review [PDF]

open access: yes, 2017
Transfusion dependent thalassemia is a hematological condition characterized by imbalance in synthesis of alpha and beta subunits of hemoglobin. The consequence of regular and repeated transfusions is iron deposition in different organs.
Nassiri, Nader, Hashemieh, Mozhgan
core   +1 more source

Iron Chelator Drugs in Transfusion Dependent Thalassemia: a Review

open access: yesArmaghane Danesh Bimonthly Journal, 2020
Background & aim: Thalassemia syndromes are the most common inherited hemoglobinopathies in the world characterized by various degrees of defective production of the alpha or beta globin chains.
M Hashemieh
doaj  

Differential effects of the type of iron chelator on the absolute number of hematopoietic peripheral progenitors in patients with β-thalassemia major

open access: yesHaematologica, 2013
Several studies have established an association between iron chelation therapy with deferasirox and hematopoietic improvement in patients with myelodysplastic syndromes. There are no data from patients with β-thalassemia major. In a cross-sectional study,
Gian Luca Forni   +8 more
doaj   +1 more source

Effects of different iron sources on growth performance, intestinal morphology, development, and cell proliferation in weanling piglets

open access: yesJournal of Nutritional Science
The current study aimed to investigate the effects of different iron sources on growth performance and small intestinal health in weaned piglets. Two hundred and forty piglets (Duroc × Large White × Landrace, 9.52 ± 1.60 kg, 40 ± 2 d) were assigned to ...
Ping Kang   +12 more
doaj   +1 more source

A Novel Combination Cancer Therapy with Iron Chelator Targeting Cancer Stem Cells via Suppressing Stemness [PDF]

open access: yes, 2019
Excess iron causes cancer and is thought to be related to carcinogenesis and cancer progression including stemness, but the details remain unclear. Here, we hypothesized that stemness in cancer is related to iron metabolism and that regulating iron ...
Matsukawa, Akihiro   +37 more
core   +1 more source

Acute iron overload aggravates blood-brain barrier disruption and hemorrhagic transformation after transient focal ischemia in rats with hyperglycemia

open access: yesIBRO Neuroscience Reports, 2022
Hemorrhagic transformation (HT) has been reported to be associated with a poor prognosis after acute ischemic stroke. Blood-brain barrier (BBB) damage is considered as the major pathophysiologic mechanism of HT.
Qian Wu   +7 more
doaj   +1 more source

The role of iron and iron chelators in zygomycosis [PDF]

open access: yesClinical Microbiology and Infection, 2009
Iron is an essential element for cell growth and development, contributing to DNA synthesis and regulating the G(1)-phase to S-phase transition. Moreover, iron is important for the virulence of the majority of microorganisms, and the function of the genes regulating iron uptake is coupled with the manifestations of the virulence phenotype.
openaire   +2 more sources

Selective elimination of quiescent cancer cells by dequalinium chloride via ROS‐mediated ferroptosis

open access: yesFEBS Open Bio, EarlyView.
Dequalinium chloride (DQ) selectively eliminates quiescent cancer cells (QCCs) by amplifying mitochondrial ROS. QCCs exhibit elevated basal ROS and limited redox‐buffering capacity, making them vulnerable to further ROS increases. DQ‐induced ROS exceeds the tolerance threshold, triggering lipid peroxidation and ferroptosis, whereas proliferating cells ...
Kotaro Miyamoto   +14 more
wiley   +1 more source

Ironing out Persisters? Revisiting the Iron Chelation Strategy to Target Planktonic Bacterial Persisters Harboured in Carbapenem-Resistant Escherichia coli

open access: yesMicroorganisms
Antibiotic resistance is a global health crisis. Notably, carbapenem-resistant Enterobacterales (CRE) pose a significant clinical challenge due to the limited effective treatment options.
Jia Hao Yeo   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy